The invention disclosed herein is a method of separation of human serum from human fresh frozen plasma (FFP). The invention also discloses a method of culturing and cryopreserving clinical grade Human Mesenchymal Stem Cells using human serum recovered from human fresh frozen plasma (FFP), under xeno-free conditions, useful for therapeutic purposes in regenerative medicine.